Patent ID: 6969533

Claim:
A beverage comprising: a. an ingestible fluid; and b. a dosage amount of an ingestible composition for treating an inflammatory tissue in a mammal, involving the inflammatory tissue selected from the group comprising underperfused tissue, inflamed joints, inflamed muscles, and wherein the dosage amount comprises: i. a glucose ingredient selected from the group consisting of glucosamine sulfate, glucosamine hydrochloride, n-acetyl glucosamine, and combinations thereof; ii. a chondroitin component selected from the group consisting of chondroitin sulfate, chondroitin hydrochloride, and combinations thereof; iii. a member of the family of araliaceae for buffering the ingestion of the glucose ingredient; and the member is a ginseng selected from the group consisting of American ginseng, Siberian ginseng, panax ginseng, and combinations thereof; iv. a calcium containing component; and v. a sulfonate having at least one methyl group.